Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen

Abstract

Objective:

To investigate the prevalence of metabolic syndrome and its associated risk factors in a cohort of university freshmen.

Design:

A cross-sectional study in a university health center in North Taiwan.

Subjects:

A total of 8226 students (mean age: 19.2±2.3 years) receiving pre-entrance health examinations and lifestyle questionnaires during the 2005–2006 academic year were recruited.

Measurements:

A fasting plasma glucose, lipids, uric acid and hepatitis B serology were measured for each subject. The prevalence of metabolic syndrome and its individual components were examined using the America Heart Association and National Heart Lung Blood Institute criteria. The risk factors for metabolic syndrome were identified using a multivariate logistic regression analysis.

Results:

The prevalence of overweight, obesity and metabolic syndrome was 12.7% (17.0% in men and 7.6% in women), 13.0% (18.4% in men and 6.4% in women) and 4.6% (6.4% in men and 2.4% in women). The risk for metabolic syndrome increased with an increase of body mass index and plasma uric acid level, and decreased with the vigorous physical activity and current alcohol drinking. Furthermore, as compared to subjects with seroprotective titers from hepatitis B vaccination (anti-HBs(+) and anti-HBc(−)), those without protective titers of anti-HBs after vaccination or without hepatitis B infection (anti-HBs(−) and anti-HBc(−)) had 34% higher risk for metabolic syndrome, and those with natural infection of hepatitis B (anti-HBc(+)) had 58% higher risk for metabolic syndrome.

Conclusions:

Overweight, obesity and metabolic syndrome were more common among men than women in university freshmen. Hepatitis B vaccination with anti-HBs(+) was associated with a lower risk of metabolic syndrome as compared to anti-HBs(−). However, hepatitis B infection presented with anti-HBc(+) was associated with a higher risk of metabolic syndrome. The interplay between hepatitis B infection, hepatitis B vaccination and metabolic syndrome needs further investigation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Ford ES, Giles WH, Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.

    Article  PubMed  Google Scholar 

  2. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004; 147: 106–112.

    Article  PubMed  Google Scholar 

  3. Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415–1428.

    Article  CAS  PubMed  Google Scholar 

  4. Park HS, Oh SW, Cho SI, Choi WH, Kim YS . The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004; 33: 328–336.

    Article  PubMed  Google Scholar 

  5. Tan CE, Ma S, Wai D, Chew SK, Tai ES . Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182–1186.

    Article  PubMed  Google Scholar 

  6. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066–3072.

    Article  CAS  PubMed  Google Scholar 

  7. Hanson RL, Imperatore G, Bennett PH, Knowler WC . Components of the ‘metabolic syndrome’ and incidence of type 2 diabetes. Diabetes 2002; 51: 3120–3127.

    Article  CAS  PubMed  Google Scholar 

  8. Rutter MK, Meigs JB, Sullivan LM, D'Agostino Sr RB, Wilson PW . Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005; 54: 3252–3257.

    Article  CAS  PubMed  Google Scholar 

  9. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.

    Article  CAS  PubMed  Google Scholar 

  10. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.

    Article  PubMed  Google Scholar 

  11. Reaven GM . Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002; 206: 286–288.

    Article  Google Scholar 

  12. James PT, Leach R, Kalamara E, Shayeghi M . The worldwide obesity epidemic. Obes Res 2001; 9: S228–S233.

    Article  Google Scholar 

  13. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM . Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006; 295: 1549–1555.

    Article  CAS  PubMed  Google Scholar 

  14. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW . Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097–1105.

    Article  CAS  PubMed  Google Scholar 

  15. Bray GA . Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89: 2583–2589.

    Article  CAS  PubMed  Google Scholar 

  16. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP . The spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999; 282: 1519–1522.

    Article  CAS  PubMed  Google Scholar 

  17. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH . Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003; 157: 821–827.

    Article  PubMed  Google Scholar 

  18. Huang TT, Kempf AM, Strother ML, Li C, Lee RE, Harris KJ et al. Overweight and components of the metabolic syndrome in college students. Diabetes Care 2004; 27: 3000–3001.

    Article  PubMed  Google Scholar 

  19. Jan CF, Chen CJ, Chiu YH, Chen LS, Wu HM, Huang CC et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study no. 10). Int J Obes Relat Metab Disord 2006; 30: 794–799.

    Article  Google Scholar 

  20. Huang KC, Lin WY, Lee LT, Chen CY, Lo H, Hsia HH et al. Four anthropometric indices and cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002; 26: 1060–1068.

    Article  PubMed  Google Scholar 

  21. WHO Expert Panel. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157–163.

    Article  Google Scholar 

  22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  PubMed  Google Scholar 

  23. Hwang LC, Bai CH, Chen CJ . Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006; 105: 626–635.

    Article  PubMed  Google Scholar 

  24. Lin YC, Yen LL, Chen SY, Kao MD, Tzeng MS, Huang PC et al. Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993–1996. Prev Med 2003; 37: 233–241.

    Article  PubMed  Google Scholar 

  25. Katzmarzyk PT, Mason C . Prevalence of class I, II and III obesity in Canada. CMAJ 2006; 174: 156–157.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chu NF . Prevalence of obesity in Taiwan. Obes Rev 2005; 6: 271–274.

    Article  PubMed  Google Scholar 

  27. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB . The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003; 163: 427–436.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lin WY, Yao CA, Wang HC, Huang KC . Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity 2006; 14: 1654–1661.

    Article  PubMed  Google Scholar 

  29. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M . Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25: 1038–1044.

    Article  CAS  PubMed  Google Scholar 

  30. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006; 19: 1055–1062.

    Article  CAS  PubMed  Google Scholar 

  31. Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy II PF, Kullo IJ . Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007; 20: 83–89.

    Article  PubMed  Google Scholar 

  32. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M . Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993; 270: 354–359.

    Article  CAS  PubMed  Google Scholar 

  33. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS . Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006; 55: 1293–1301.

    Article  CAS  PubMed  Google Scholar 

  34. Baldus S, Koster R, Chumley P, Heitzer T, Rudolph V, Ostad MA et al. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 2005; 39: 1184–1190.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Evans JL, Maddux BA, Goldfine ID . The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005; 7: 1040–1052.

    Article  CAS  PubMed  Google Scholar 

  36. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 1855–1859.

    Article  CAS  PubMed  Google Scholar 

  37. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD et al. Hepatitis B virus infection in adolescents in a rural township—15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006; 24: 759–765.

    Article  PubMed  Google Scholar 

  38. Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY . Seroprevalence of hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national hepatitis-B vaccination program. J Med Virol 2007; 79: 138–143.

    Article  CAS  PubMed  Google Scholar 

  39. Lao TT, Chan BC, Leung WC, Ho LF, Tse KY . Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol 2007; 47: 46–50.

    Article  CAS  PubMed  Google Scholar 

  40. Li-Ng M, Tropp S, Danoff A, Bini EJ . Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis 2007; 39: 549–556.

    Article  CAS  PubMed  Google Scholar 

  41. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes Relat Metab Disord 2005; 29: 281–286.

    Article  CAS  Google Scholar 

  42. Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes Relat Metab Disord 2007; 31: 87–96.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was partially funded by the National Science Council of Taiwan (NSC 95-2314-B-002-146-MY2). We thank Dr Janice Lin at Tufts University for kindly reviewing this manuscript. We also thank all the staffs at the Health Center of National Taiwan University for their efforts in the health examination and data collection of these students.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K-C Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yen, SL., Chiu, TY., Lin, YC. et al. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Int J Obes 32, 474–480 (2008). https://doi.org/10.1038/sj.ijo.0803753

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803753

Keywords

This article is cited by

Search

Quick links